Podcast: US FDA’s Artificial Intelligence Guidance May Need Congress And Is At Least A Year Away, Expert Says

Zach Rothstein, the top artificial intelligence and machine learning lobbyist at device industry advocacy group AdvaMed, wrote to the US FDA with recommendations on how to regulate AI/ML devices. He sat down with Medtech Insight to break down the topic's most important issues.

AdvaMed's Zach Rothstein working at his office in Washington, D.C. As the top lobbyist for AI/ML, he's working to get US FDA on the same page as industry. • Source: Ferdous Al-Faruque

More from Regulation

More from Policy & Regulation